Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Intravenous(IV) Therapy and Vein Access Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Intravenous(IV) Therapy and Vein Access Market Status and Forecast (2016-2027)
      • 1.3.2 Global Intravenous(IV) Therapy and Vein Access Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Intravenous(IV) Therapy and Vein Access Supply by Company

    • 2.1 Global Intravenous(IV) Therapy and Vein Access Sales Value by Company
    • 2.2 Intravenous(IV) Therapy and Vein Access Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Intravenous(IV) Therapy and Vein Access Market Status by Category

    • 3.1 Intravenous(IV) Therapy and Vein Access Category Introduction
      • 3.1.1 Infusion Pumps
      • 3.1.2 Implantable Ports
      • 3.1.3 Intravenous Catheters
      • 3.1.4 Hypodermic Needles
      • 3.1.5 Other
    • 3.2 Global Intravenous(IV) Therapy and Vein Access Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Intravenous(IV) Therapy and Vein Access Market Status by End User/Segment

    • 4.1 Intravenous(IV) Therapy and Vein Access Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinics
      • 4.1.3 Other
    • 4.2 Global Intravenous(IV) Therapy and Vein Access Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Intravenous(IV) Therapy and Vein Access Market Status by Region

    • 5.1 Global Intravenous(IV) Therapy and Vein Access Market by Region
    • 5.2 North America Intravenous(IV) Therapy and Vein Access Market Status
    • 5.3 Europe Intravenous(IV) Therapy and Vein Access Market Status
    • 5.4 Asia Pacific Intravenous(IV) Therapy and Vein Access Market Status
    • 5.5 Central & South America Intravenous(IV) Therapy and Vein Access Market Status
    • 5.6 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Status

    6 North America Intravenous(IV) Therapy and Vein Access Market Status

    • 6.1 North America Intravenous(IV) Therapy and Vein Access Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Intravenous(IV) Therapy and Vein Access Market Status

    • 7.1 Europe Intravenous(IV) Therapy and Vein Access Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Intravenous(IV) Therapy and Vein Access Market Status

    • 8.1 Asia Pacific Intravenous(IV) Therapy and Vein Access Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Intravenous(IV) Therapy and Vein Access Market Status

    • 9.1 Central & South America Intravenous(IV) Therapy and Vein Access Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Status

    • 10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Category and by End User/Segment

    • 12.1 Global Intravenous(IV) Therapy and Vein Access Sales Value Forecast (2022-2027)
    • 12.2 Global Intravenous(IV) Therapy and Vein Access Forecast by Category
    • 12.3 Global Intravenous(IV) Therapy and Vein Access Forecast by End User/Segment

    13 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Region/Country

    • 13.1 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teleflex
      • 14.1.1 Company Information
      • 14.1.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.1.3 Teleflex Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Smiths Group
      • 14.2.1 Company Information
      • 14.2.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.2.3 Smiths Group Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Medtronic
      • 14.3.1 Company Information
      • 14.3.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.3.3 Medtronic Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Hospira(ICU Medical)
      • 14.4.1 Company Information
      • 14.4.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.4.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Fresenius Kabi
      • 14.5.1 Company Information
      • 14.5.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 C. R. Bard
      • 14.6.1 Company Information
      • 14.6.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.6.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Becton Dickinson
      • 14.7.1 Company Information
      • 14.7.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.7.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Baxter International
      • 14.8.1 Company Information
      • 14.8.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.8.3 Baxter International Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 B. Braun
      • 14.9.1 Company Information
      • 14.9.2 Intravenous(IV) Therapy and Vein Access Product Introduction
      • 14.9.3 B. Braun Intravenous(IV) Therapy and Vein Access Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Intravenous(IV) Therapy and Vein Access market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Intravenous(IV) Therapy and Vein Access market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Infusion Pumps
      Implantable Ports
      Intravenous Catheters
      Hypodermic Needles
      Other

      Segmented by End User/Segment
      Hospital
      Clinics
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Teleflex
      Smiths Group
      Medtronic
      Hospira(ICU Medical)
      Fresenius Kabi
      C. R. Bard
      Becton Dickinson
      Baxter International
      B. Braun
      Buy now